Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
165K
-
Shares change
-
+17.7K
-
Total reported value, excl. options
-
$448K
-
Value change
-
+$49.8K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$2.72
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q4 2017
7 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q4 2017.
Co-Diagnostics, Inc. - Common Stock (CODX) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 165K shares
of 38.5M outstanding shares and own 0.43% of the company stock.
Largest 8 shareholders include HighTower Advisors, LLC (97.5K shares), Vanguard Group Inc (30K shares), MILLENNIUM MANAGEMENT LLC (14.5K shares), OxFORD Asset Management LLP (10.5K shares), TWO SIGMA SECURITIES, LLC (10.2K shares), Tower Research Capital LLC (TRC) (1.99K shares), MORGAN STANLEY (0 shares), and UBS Group AG (937 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.